158 related articles for article (PubMed ID: 11261279)
1. Identification and characterisation of minimal residual disease in solid tumors.
Pantel K; Otte M
Acta Med Austriaca Suppl; 2000; 52():8-12. PubMed ID: 11261279
[TBL] [Abstract][Full Text] [Related]
2. Molecular profiling of micrometastatic cancer cells.
Pantel K; Hosch SB
Ann Surg Oncol; 2001 Oct; 8(9 Suppl):18S-21S. PubMed ID: 11599890
[TBL] [Abstract][Full Text] [Related]
3. Disseminated tumor cells: diagnosis, prognostic relevance, and phenotyping.
Pantel K; Otte M
Recent Results Cancer Res; 2001; 158():14-24. PubMed ID: 11092029
[TBL] [Abstract][Full Text] [Related]
4. Occult micrometastasis: enrichment, identification and characterization of single disseminated tumour cells.
Pantel K; Otte M
Semin Cancer Biol; 2001 Oct; 11(5):327-37. PubMed ID: 11562175
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and significance of minimal residual disease in patients with colorectal carcinoma].
von Knebel Doeberitz M; Koch M; Weitz J; Herfarth C
Zentralbl Chir; 2000; 125 Suppl 1():15-9. PubMed ID: 10929641
[TBL] [Abstract][Full Text] [Related]
6. [Minimal residual disease in gastrointestinal tumors: tumor detection in bone marrow, blood and lymph nodes].
Rosenberg R; Nekarda H; Thorban S; Siewert JR
Acta Med Austriaca Suppl; 2002; 59():42-53. PubMed ID: 12506760
[TBL] [Abstract][Full Text] [Related]
7. Detection and clinical significance of occult tumour cells in colorectal cancer.
Tsavellas G; Patel H; Allen-Mersh TG
Br J Surg; 2001 Oct; 88(10):1307-20. PubMed ID: 11578283
[TBL] [Abstract][Full Text] [Related]
8. Minimal residual disease, the rationale for adjuvant therapy in epithelial malignancies.
Nissan A
J Surg Oncol; 2007 Sep; 96(3):185-7. PubMed ID: 17443732
[No Abstract] [Full Text] [Related]
9. [Micrometastases in pediatric oncology].
Bernard F; Aerts I; Margueritte G; Astruc J
Bull Cancer; 2001 Jun; 88(6):577-80. PubMed ID: 11459704
[TBL] [Abstract][Full Text] [Related]
10. Detection of disseminated tumor cells: strategies and diagnostic implications.
Zehentner BK
Expert Rev Mol Diagn; 2002 Jan; 2(1):41-8. PubMed ID: 11963801
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
[TBL] [Abstract][Full Text] [Related]
12. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
Riethdorf S; Pantel K
Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
[TBL] [Abstract][Full Text] [Related]
13. Detection of occult metastasis in lymph nodes from colorectal cancer patients: a multiple-marker reverse transcriptase-polymerase chain reaction study.
Chen G; McIver CM; Texler M; Lloyd JM; Rieger N; Hewett PJ; Sen Wan D; Hardingham JE
Dis Colon Rectum; 2004 May; 47(5):679-86. PubMed ID: 15037935
[TBL] [Abstract][Full Text] [Related]
14. [Significance of minimal residual disease for the estimation of the prognosis and for therapeutic decisions in solid tumors].
Hinterberger W; Buxhofer V; Ogris E; Zelenka P; Kier P; Ruckser R; Dorner S; Habertheuer KH; Vedovelli H; Schindler S; Hinterberger-Fischer M
Acta Med Austriaca Suppl; 2002; 59():2-8. PubMed ID: 12506753
[TBL] [Abstract][Full Text] [Related]
15. Disseminated tumor cells versus micrometastasis: definitions and problems.
Hermanek P
Anticancer Res; 1999; 19(4A):2771-4. PubMed ID: 10470239
[TBL] [Abstract][Full Text] [Related]
16. Micrometastatic disease in breast cancer: clinical implications.
Ignatiadis M; Georgoulias V; Mavroudis D
Eur J Cancer; 2008 Dec; 44(18):2726-36. PubMed ID: 19056036
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumour cells in breast cancer--review.
Vertakova KB; Sanislo L; Spanik S; Svec J; Ondrus D
Klin Onkol; 2010; 23(2):86-91. PubMed ID: 20465086
[TBL] [Abstract][Full Text] [Related]
18. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
[TBL] [Abstract][Full Text] [Related]
19. Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
Lang JE; Hall CS; Singh B; Lucci A
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1463-72. PubMed ID: 17944570
[TBL] [Abstract][Full Text] [Related]
20. Detection of minimal residual disease in patients with cancer: a review of techniques, clinical implications, and emerging therapeutic consequences.
Köstler WJ; Brodowicz T; Hejna M; Wiltschke C; Zielinski CC
Cancer Detect Prev; 2000; 24(4):376-403. PubMed ID: 11059569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
